Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ADL+2.0: Intervention for Prevention of Cognitive Decline in Community-dwelling Older Adults.

NCT07141160 is registered in ClinicalTrials.gov with Tan Tock Seng Hospital as lead sponsor.

NCT NCT07141160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07141160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ADL+2.0: Intervention for Prevention of Cognitive Decline in Community-dwelling Older Adults.
Lead sponsor
Tan Tock Seng Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
May 8, 2025
Completion date
December 31, 2029
Enrollment
255 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive decline